| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nabriva Therapeutics plc | Chief Medical Officer | Stock Appreciation Right | 71,500 | 11 Aug 2022 | Direct | ||
| Nabriva Therapeutics plc | Chief Medical Officer | Phantom Shares | 35,700 | 11 Aug 2022 | Direct | ||
| Nabriva Therapeutics plc | Chief Medical Officer | Restricted Stock Units | 0 | 11 Aug 2022 | Direct | ||
| Nabriva Therapeutics plc | Chief Medical Officer | Share Options | 0 | 11 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465922091487-guico-pabia-christine-j-2022-08-11 | Nabriva Therapeutics plc | 11 Aug 2022 | 4 | $0 | 4 | Chief Medical Officer | 15 Aug 2022, 20:34 |
| /report/000110465922010491-guico-pabia-christine-j-2022-01-28 | Nabriva Therapeutics plc | 28 Jan 2022 | 2 | $0 | 4 | Chief Medical Officer | 01 Feb 2022, 17:40 |
| /report/000110465921132463-guico-pabia-christine-j-2021-10-29 | Nabriva Therapeutics plc | 29 Oct 2021 | 1 | $0 | 4 | Chief Medical Officer | 01 Nov 2021, 18:10 |
| /report/000110465921124304-guico-pabia-christine-j-2021-10-01 | Nabriva Therapeutics plc | 01 Oct 2021 | 0 | $0 | 3 | Chief Medical Officer | 07 Oct 2021, 21:10 |